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Stomatin is a member of a large family of proteins including prohibitins, HflK/C, flotillins, mechanoreceptors and plant defense proteins, that are
thought to play a role in protein turnover. Using different proteomic approaches, we and others have identified SLP-2, a member of the stomatin gene
family, as a component of the mitochondria. In this study, we show that SLP-2 is strongly associated with the mitochondrial inner membrane and that it
interacts with prohibitins. Depleting HeLa cells of SLP-2 lead to increased proteolysis of prohibitins and of subunits of the respiratory chain complexes I
and IV. Further supporting the role of SLP-2 in regulating the stability of specific mitochondrial proteins, we found that SLP-2 is up-regulated under
conditions of mitochondrial stress leading to increased protein turnover. These data indicate that SLP-2 plays a role in regulating the stability of
mitochondrial proteins including prohibitins and subunits of respiratory chain complexes.
© 2008 Elsevier B.V. All rights reserved.Keywords: Mitochondria; Stomatin; Prohibitin; Chaperone; AAA protease; Protein turnover1. Introduction
Stomatin is a plasmamembrane protein that was first identified
in human erythrocytes [1]. Homologues of this protein have been
found in a wide range of cell types and organisms such as zebra-
fish, Drosophila, Caenorhabditis elegans, plants and bacteria.
Stomatin is the founding member of a family of proteins which
includes SLP-1, 2 and 3 in mammals. The homology between
members of this family mainly resides in the stomatin domain,
which is composed of (L/I/V) (K/R) repeats. In addition, due to
the presence of a band 7 motif, stomatin has been predicted to
belong to the SPFH family which comprises stomatins, prohibit-
ins, flotillins and HflK/C bacterial proteases [2]. Finally, SLP-1
and SLP-3 also share an N-terminal transmembrane domain with
stomatin, a feature absent from SLP-2.⁎ Corresponding author. Tel.: +41 223796443; fax: +41 223796442.
E-mail address: jean-claude.martinou@cellbio.unige.ch (J.-C. Martinou).
0167-4889/$ - see front matter © 2008 Elsevier B.V. All rights reserved.
doi:10.1016/j.bbamcr.2008.02.006The function of stomatin and SLPs is still unclear. Never-
theless, since they belong to a superfamily of proteins involved in
protein turnover, stomatins have been suggested to fulfill a similar
function [2,3].
Recently, in an effort to establish the proteome of the mito-
chondrial inner membrane (MIM), we have identified SLP-2 as a
component associated with the MIM [4]. The same protein was
also found to be a component of human and plant mitochondria in
recent proteomic surveys [5–9]. Here, we have confirmed that
SLP-2 is a protein attached to the MIM and we further in-
vestigated its function in the mitochondria. Our results show that
SLP-2 interacts with prohibitins and that depleting HeLa cells of
SLP-2 are accompanied by a decrease in the protein levels of
prohibitins and those of subunits of complexes I and IV due to an
enhanced proteolysis by metalloproteases. Furthermore we found
that SLP-2 is up-regulated under conditions of mitochondrial
stress leading to increased protein turnover. These data suggest
that SLP-2 plays a role in regulating the stability of prohibitins and
subunits of respiratory chain complexes.
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2.1. Cell culture and reagents
HeLa, 293T, MEF and Cos-7 cells were cultured in DMEM+10% fetal
bovine serum, 100 U/ml penicillin, 0.1 mg/ml streptomycin and 2 mM glutamine
and maintained in 5% CO2 at 37 °C. Stress assays were performed by culturing
cells in medium containing 50 μg/ml or 100 μg/ml of chloramphenicol (Fluka)
for 96 h. Etoposide (100 μM) was added to the cells for 1 h after 72 h of
transfection and the cells were further cultured in fresh medium for 24 h.
Cycloheximide (Sigma) treatment of HeLa cells was performed at 30 μg/ml for 0,
6 or 9 h and phenanthroline (Sigma) was used at 5 mM for 30 min.
2.2. DNA cloning
All the constructs in this study were generated by standard PCR cloning
procedures using a mouse liver marathon-ready cDNA library (Clontech). The
amplified sequences were C-terminally fused to HA (YPYDVPDYA) tags by PCR
and cloned into the pCI mammalian expression vector (Promega). The first 150
nucleotides of SLP-2 (1–50 first amino acids) were amplified by PCR and cloned
into the pEGFP-N1 vector (Clontech). All the constructs were sequenced to verify
the fidelity of the cDNA sequences obtained.
2.3. Immunocytochemistry
For detection of endogenous SLP-2, the cells were fixed with methanol and
the antibody to SLP-2 used at a 1:100 dilution.
2.4. Isolation of mitochondria from HeLa cells
HeLa cells were seeded on 14 cm dish at 80% of confluency for 1 h before
transfection with 25 μg of DNA using the classical Ca/phosphate method. After
48 h of expression, HeLa cells were treated as described by Eskes et al. [10] to
prepare mitochondrial and cytosolic fractions.
2.5. Preparation of the different subcompartments of mouse liver
mitochondria
Mouse liver mitochondria, mitoplasts, MIM and MOM were purified as
described by Da Cruz et al. [4].
2.6. Mitoplasts preparation and proteinase K assay
100 μg of the mitochondrial fraction from HeLa cells was incubated with
2 mg/ml of digitonin (Serva) in a final volume of 100 μl of MB buffer for 20 min
on ice. The solubilised fractions were then centrifuged at 10,000 g for 10 min at
4 °C. The pellet was washed with 1 ml of MB buffer and centrifuged again in the
same conditions. The resulting pellet contains the mitoplast fraction.
Mitoplasts isolated from untransfected HeLa cells were resuspended at 0.5 mg/
ml inMBbuffer in the presence of 0.25μg/ml of proteinaseK (Invitrogen) for 30min
on ice. The digestion was stopped after addition of 1 mM PMSF. The digested
fraction was subsequently centrifuged at 10,000 g for 5 min at 4 °C. The pellet was
further lysed in 25 μl of 1× SDS loading buffer and analyzed by Western blotting.
2.7. Gel filtration chromatography
500μg ofmitochondria isolated from untransfectedHeLa cells were solubilised
in 25 mMHepes, 300 mMNaCl, 1% Triton X-100 and protease inhibitors (Roche)
for 2 h on ice. The solubilised mitochondria were further centrifuged at 100,000 g
for 30 min. The supernatant was injected into a Superose 6 column connected to a
FPLC system. 2 ml fractions were collected and TCA precipitated.
2.8. Immunoprecipitation
500 μg of mitochondria isolated from untransfected or transfected HeLa
cells with pCI, SLP2-HA were solubilised with Otter buffer (10 mM Hepes,143 mM KCl, 5 mM MgCl2, 1 mM EGTA, pH 7.4) supplemented with 1% of
Nonidet P-40 and protease inhibitors (Roche) for 2 h on ice. The solubilised
mitochondria were further centrifuged at 100,000 g for 30 min. The supernatant
was incubatedwith 10μg of anti-HA, anti-SLP-2 or anti-prohibitin-1 antibody on
rotation for 16 h at 4 °C. Then, 30 μl of protein A-Sepharose beads (Amersham)
were added and incubated on rotation for 4 h at 4 °C. Protein A-Sepharose was
recovered by centrifugation and washed four times with the Otter buffer. The
washed Sepharose was suspended in 1× loading buffer analyzed by Western
blotting or silver nitrate staining.
2.9. Cross-linking
2 mg of mitochondria isolated from HeLa cells were suspended inMB buffer
(supplemented with proteinase inhibitors) at 2 mg/ml and incubated with 1 mM
DSP for 30min at RT. The reaction is further quenched by adding 50mMTris pH
8 for 30 min at RT. The cross-linked mitochondria were spun at 10,000 g for
10 min and the pellet was solubilised with RIPA buffer (50 mM Tris pH 8,
150 mM NaCl, 0.1% SDS, 1% Nonidet P-40, supplemented with protease
inhibitors) for 16 h at 4 °C. The sample was further centrifuged at 10,000 g for
10 min and the supernatant was subsequently incubated with the anti-SLP-2
antibody to immunoprecipitate the endogenous SLP-2 cross-linked complex as
described above. However, the washes were done with the RIPA buffer. Finally
the washed Sepharose beads were incubated with 1× loading buffer containing
5% β-mercaptoethanol for 5 min at 100 °C in order to de-cross-link the immu-
noprecipitated fraction.
2.10. Antibodies
Anti SLP-2 antibody was produced by immunizing rabbits with synthetic
peptide with a sequence CRKRATVLESEGTRES. The monoclonal anti-
prohibitin-1 antibody was from Neomarkers, the anti-HSP70 from ABR, the
anti-COX4 from Molecular Probes, the anti-TIM23 and anti-TIM44 from BD
Biosciences, the anti-HA from Covance and the anti-GAPDH from Abcam. The
polyclonal antibodies were the anti-fumarase from Nordic Immunology, the anti
SMAC-Diablo from ProSci, anti-prohibitin-2 from Upstate and the anti-hFis1
from Apotech. The goat anti-VDAC (N-18) was from Santa Cruz. The anti-
complex I (ND6), anti-complex II and anti-complex III (core 2) antibodies were
kindly provided by R. Rossignol (University of Bordeaux).
2.11. Protein digestion and liquid chromatography–mass spectrometry
(LC–MS/MS)
The protein spots were excised with a pipette tip from the gel and transferred to
96-well plates. In-gel proteolytic cleavage was performed automatically in the
robotic workstation Investigator ProGest (Perkin Elmer Life Sciences). The
digestion protocol includedwashing of the gel pieces with ammonium bicarbonate,
cysteine reduction with DTT and alkylation by iodoacetamide followed by over-
night digestion with trypsin (Promega) and extraction of the resulting peptides in
30% (v/v) acetonitrile, 2% (v/v) formic acid. Peptide mixtures were concentrated
and resuspended in 10 μl of 0.5% formic acid before LC–MS/MS analysis. Liquid
chromatography–tandem mass spectrometry was performed on a SCIEX QSTAR
PULSAR (Concord, Ontario, Canada) hybrid quadrupole-time of flight instrument
equipped with a nanoelectrospray source and interfaced to an LC-Packings Ulti-
mateHPLC system. Peptideswere separated on a PepMap reversed-phase capillary
C18 (75μm ID×15 cm) column at a flow rate of 200 nl/minwith a 52-min gradient
of acetonitrile (0–40%). The instrument controlling Analyst software was used
to performpeak detection and automatically select peptideswith charge states 2+ to
4+ for collision-induced fragmentation. The resulting sets of CID spectra were
bundled and used to search with the MASCOT software a composite protein
sequence database formed by merging SWISSPROT and TrEMBL.
2.12. Cell lysis
Whole cells were lysed for 20 min on ice in lysis buffer (10 mM Hepes,
300 mM KCl, 5 mM MgCl2, 1 mM EGTA, 1% Nonidet P-40, 0.1% SDS, pH
7.4) supplemented with protease inhibitors (Roche). The lysate was centrifuged
at 10,000 g for 10 min. 15 µg of total protein was loaded per lane of SDS/PAGE.
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shRNA targeting the SLP-2 transcript was synthesized in vivo using the
recently developed pRETRO vector (generously provided by Dr. Agami) and
previously described in [11,12]. Nucleotides 697–715 of the SLP-2 transcript were
chosen as targets for RNA interference. To generate pRETRO SLP-2 shRNA, the
pRETRO vector was digested with BglII and HindIII and the annealed oligos (5′
GatccccGGCTGAACAGATAAATCAGttcaagagaCTGATTTATCTGTT-
CAGCCtttttggaaa3′) and (5′AgcttttccaaaaaGGCTGAACAGATAAATCAGtctctt-
gaaCTGATTTATCTGTTCAGCCggg3′) were ligated into the vectors. Similarly,
as a control, we generated a pRETRO Luc shRNA, which targets the Luciferase
transcript.
For transient transfections, HeLa cells were plated on 10 cm dishes and
transfected with 20 µg of the appropriate pRETRO constructs using Ca/phosphate
method. 24 h after transfection, puromycin (Calbiochem)was added at 3 µg/ml and
the cells were incubated for a further 24 h. After puromycin incubation the cells
were washed and left to recover for a further 72 h.
For infection of HeLa or MEF cells, the retroviral supernatants were produced
by transfecting 293T cells with 20 µg of pRETRO shRNA vector, 15 µg of
pCMVgag vector (Packaging plasmid) and 5 µg of pMD2G vector (Envelope
plasmid) by calcium-phosphatemethod on a 10 cmdish. 24 h post-transfection, the
tissue culture medium was centrifuged at 1000 g for 10 min at 4 °C and filtered
through a 0.45 μm filter. The viral supernatant was used to infect HeLa cells for at
least 6 h and allowed to recover for 12 hwith freshmedium. The infected cells were
selected with puromycin 2 μg/ml for 48 h.
2.14. RNA extraction and Q-PCR
Real-time quantitative RT-PCR (Q-PCR) was performed to determine the
complex III core 2 and complex IV subunit 4 mRNA levels in cells transfected
either with Ctrl or SLP-2 shRNA after 120 h of transfection. Total RNA from
cells transfected with Ctrl shRNA or SLP-2 shRNA was isolated with Trizol
(Invitrogen) and prepared for reverse transcription according to manufacturer's
instructions. Q-PCR was performed using the iQSYBR Green supermix (Bio-
Rad)with the iCycler iQ detection system according tomanufacturer's instructions.
Elongation translation factor 1 (EEF1A1), TATA box-binding protein (TBP) and
the transferrin receptor (TFRC) genes were also measured as endogenous ref-
erences across all experimental conditions. The fold changes in complex III or
complex IV mRNAs expression were calculated using a previously published
formula [13].
3. Results
3.1. SLP-2 is a mitochondrial inner membrane protein
In an earlier study, we identified SLP-2 as a protein attached
to the MIM [4]. In order to confirm the mitochondrial lo-
calization of SLP-2 we generated a rabbit polyclonal antibody
against SLP-2. In HeLa cell lysates, this antibody recognizes
a single band migrating at the expected molecular weight of
SLP-2 (38 kDa; Fig. 1A). This band was not detected in HeLa
cells depleted of SLP-2 by RNA interference, thus confirming
the specificity of the antibody (Fig. 1A). Western blotting anal-
ysis of subcellular fractions of HeLa cells revealed that SLP-2 is
present in the mitochondrial enriched fraction (Fig. 1B). This
localization was confirmed by immunodetection of endogenous
SLP-2 (Fig. 1C) and by detection of exogenous SLP-2 fused at
its C-terminus with an HA tag (Fig. 1C) which both co-localized
with specific mitochondrial markers (Fig. 1C). The targeting of
several proteins of the MIM requires an N-terminal mitochon-
drial localization signal (MLS) [14]. Deletion of the first 50
amino acid sequence of the N-terminus of SLP-2, which
according to the MITOPROT database contains a mitochondrialsignal peptide, abrogated the mitochondrial targeting and led to
the diffuse cytosolic localization of the mutant protein (1–50Δ)
SLP2-HA (Fig. 1C). To further confirm that this region contains
the MLS, the first 50 amino acid sequence of the N-terminus
of SLP-2 was fused to a GFP protein and its localization was
assessed. As shown in Fig. 1C, this GFP fusion protein (SLP2
(1–50)-GFP) co-localized with Mitotracker Red, indicating that
the first 50 amino acid sequence of SLP-2 contains a MLS.
Altogether, these data demonstrate that SLP-2 localizes to the
mitochondria.
To validate the association of SLP-2 with MIM inferred from
our proteomic study [4], we further analyzed the submitochondrial
localization of SLP-2. The results shown in Fig. 1D indicated that
SLP-2 is highly enriched in purified MIM and is resistant to alkali
and proteinase K treatments in mitochondria (Fig. 1E and data not
shown). To further assess the topology of SLP-2 regarding the
MIM we studied the accessibility of SLP-2 to proteinase K (PK)
by treating mitoplasts, obtained from mitochondria isolated from
HeLa cells, with PK. As shown in Fig. 1F, treatment of the
mitoplasts with PK led to a complete degradation ofMIM proteins
facing the IMS such as TIM23, while TIM44 (a MIM protein
facing the matrix) and HSP70 (a matrix protein) were unaffected.
SLP-2 was only partially proteolysed as evidenced by the
appearance of a lower molecular weight SLP-2 band. Altogether,
these data suggest that SLP-2 is attached to the MIM, facing the
IMS, in such a manner that its accessibility to proteases is limited.
3.2. SLP-2 can be immunoprecipitated with prohibitins
In an effort to elucidate the function of SLP-2, we searched for
SLP-2 interacting proteins. First we assessed whether SLP-2 was
present in a high molecular weight complex using gel filtration
chromatography. This showed that endogenous SLP-2 or over-
expressed SLP2-HAwas present in a fraction corresponding to a
molecular weight of 250 kDa (Supplementary Fig. 1A and data
not shown), suggesting that SLP-2 is present in a multi-protein
complex. To identify the components of this complex, SLP2-HA
was immunoprecipitated from a mitochondrial fraction isolated
from HeLa cells over-expressing SLP2-HA. Using an anti-HA
antibody, SLP2-HA was immunoprecipitated as a doublet. Of
note, mass spectrometric analysis respectively identified the
upper and lower bands as the full length and an N-terminally
cleaved form of SLP-2 lacking the predicted mitochondrial signal
sequence (Supplementary Fig. 1B and data not shown). Silver
nitrate staining analysis of the immunoprecipitated fraction re-
vealed the presence of several other bands in addition to those
corresponding to SLP-2 (Fig. 2A). Two of these bands were
identified as prohibitins 1 and 2 by LC/MS/MS, and their identity
was confirmed by Western blotting using anti-prohibitin-1 and
anti-prohibitin-2 antibodies (Fig. 2B). Ectopically expressed
SLP-2 and endogenous prohibitin-1 could also be co-precipitated
using an anti-prohibitin-1 antibody (Fig. 2C). To avoid possible
artifacts due to over-expression of proteins, we tested whether
endogenous SLP-2 and prohibitin-1 also interact. As shown in
Fig. 2D, prohibitin-1 was immunoprecipitated using an anti-SLP-
2 antibody but in small quantities compared to the protein input.
We hypothesized that this was due to a weak interaction between
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NP40) necessary to extract these proteins. Therefore, to have a
better estimate of the level of interaction between these proteins
and to eliminate the possibility that the two proteinsmight interact
following mitochondrial membrane extraction, mitochondria
isolated from HeLa cells were treated with the cell permeableFig. 1. SLP-2 is a mitochondrial inner membrane protein. A) HeLa cells were transfec
(SLP-2 shRNA) for 120 h as described inMaterials and methods. An equal amount of
using the anti-SLP-2 antibody. Tubulin was used as a loading control. B) HeLa cell
(M) mitochondrial fraction and (C) cytosolic fraction were analyzed by Western
mitochondria and the cytosol respectively. C) Immunocytochemistry of endogenous SL
HA tagged SLP-2 fusion protein or SLP-2 lacking the first 50 amino acids fused to
antibody. The N-terminally first 50 amino acids of SLP-2 fused to a GFP protein at
localization was assessed and compared with the Mitotracker Red (MtrkR) staining.
membranes (MIM andMOM respectively) frommouse liver were prepared as describe
Western blotting using the indicated antibodies. E)Mitochondria isolated fromHeLa c
by SDS-PAGE andWestern blotting using the indicated antibodies. F)Mitochondria is
which were further treated with 0.25 μg/ml of proteinase K for 30 min on ice. The
blotting. hFis1 was taken as a marker for the mitochondrial outer membrane; SMAC-D
mitochondrial inner membrane markers and HSP70 as the mitochondrial matrix marcross-linker DSP and SLP-2was immunoprecipitated. As shown in
Fig. 2E, higher amounts of prohibitin-1 were co-precipitated with
SLP-2. Furthermore,Western blotting analysis of themitochondrial
fractions obtained by gel filtration chromatography (Supplemen-
tary Fig. 1A) revealed that prohibitin-1 and prohibitin-2 are present
in the 250 kDa complex, as SLP-2.Altogether these results stronglyted with the pRETRO Luc shRNA (Ctrl shRNA) or the pRETRO SLP-2 shRNA
proteins (20 µg) from the respective cell lysates was analyzed byWestern blotting
s were fractionated as outlined in Materials and methods. (T) Total cell extract,
blotting using the hFis1 and lactate dehydrogenase (LDH) as markers of the
P-2 using a rabbit antibody raised against SLP-2 and of C-terminally (SLP2-HA)
HA tag at the C-terminus ((1–50Δ)SLP2-HA) using an anti-HA monoclonal
the C-terminus (SLP2(1–50)-GFP) was transfected into HeLa and 24 h later its
D) Purified mitochondria (M), mitoplasts (Mp), mitochondrial inner and outer
d inMaterials andmethods. An equal amount of proteins (25 µg) was analyzed by
ells were treated with sodium carbonate (seeMaterials andmethods) and analyzed
olated fromHeLa cells were treatedwith 2mg/ml of digitonin to obtainmitoplasts
levels of endogenous SLP-2 protein were assessed by SDS-PAGE and Western
iablo as the intermembrane space marker; prohibitin-1, TIM23 and TIM44 as the
ker.
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are part of the same protein complex.
3.3. SLP-2 is required for the stability of prohibitins and
subunits of respiratory complexes I and IV
Mitochondrial inner membrane proteins such as prohibitins
have previously been shown to assist the proper folding andFig. 2. SLP-2 interacts with prohibitins. A)Mitochondria isolated fromHeLa cells tran
was immunoprecipitated with the anti-HA antibody. Immunoprecipitates were revea
(light chain of the antibody) are indicated with an asterisk. The dark arrowhead corres
from HeLa cells transfected either with SLP2-HA (1) or the empty expression vecto
antibody. Immunoprecipitates were analyzed byWestern blotting using the anti-HA, a
the mitochondrial fraction used for immunoprecipitation. C) Immunoprecipitation
prohibitin-1 antibody. Immunoprecipitates were analyzed by Western blotting usi
immunoprecipitated from mitochondria isolated from untransfected HeLa cells. The i
anti-prohibitin-1 antibodies. The second lane corresponds to mitochondria isolated f
beads and the third lane corresponds to the protein A-Sepharose beads incubated with
heavy chain. E) Mitochondria isolated from HeLa cells transfected either with SLP2-H
immunoprecipitated with anti-SLP-2 antibody. The immunocomplexes were de-cross-
using anti-SLP-2 and anti-prohibitin-1 antibodies. The asterisks correspond to the IgG
mitochondrial fraction used for immunoprecipitation.assembly of respiratory complexes [15–19]. Since it has been
proposed that stomatins are involved in regulating protein stability
[2,3], we examinedwhether the stability of mitochondrial proteins
was altered in HeLa cells depleted of SLP-2 by RNA interference.
As shown in Fig. 3A and Supplementary Fig. 2A, the protein
levels of ND6 (a subunit of complex I), COX4 (complex IV),
prohibitin-1 and prohibitin-2 were decreased in SLP-2 depleted
cells (33.9±12.5%, 30.2±16.1%, 38.3±9.2% and 31.3±13.6%;sfected either with SLP2-HA (1) or pCI vector (2) were solubilised and SLP2-HA
led by silver nitrate staining. IgG HC (heavy chain of the antibody) and IgG LC
ponds to the bands that were analyzed by LC/MS/MS. B) Mitochondria isolated
r (2) were solubilised and SLP2-HAwas immunoprecipitated with the anti-HA
nti-prohibitin-1 and prohibitin-2 antibodies. The input lane corresponds to 10% of
of the fractions described above was performed with the anti-HA or the anti-
ng the anti-HA and anti-prohibitin-1 antibodies. D) Endogenous SLP-2 was
mmunoprecipitates were analyzed by Western blotting using the anti-SLP-2 and
rom untransfected HeLa cells and incubated only with the protein A-Sepharose
the anti-SLP-2 antibody in the IP buffer only. The asterisk corresponds to the IgG
A (1) or pCI vector (2) were cross-linked with DSP and endogenous SLP-2 was
linked as described inMaterials and methods, before analysis byWestern blotting
heavy and light chains. Input lanes in panels C and D correspond to 10% of the
Fig. 3. SLP-2 is required to maintain protein levels of specific components of the respiratory chain as well as those of prohibitin-1. A) HeLa cells were infected with the
Ctrl shRNA or SLP-2 shRNA as outlined in Materials and methods. Lysates of the respective infected cells were analyzed by Western blotting with the indicated
antibodies. B) HeLa cells were transiently transfected with the Ctrl shRNA or SLP-2 shRNA as outlined in Materials and methods. After 96 h of transfection, the cells
were treated with 30 μg/ml of cycloheximide (CHX) for 0, 3, 6, and 9 h. Lysates of the respective treated cells were analyzed by Western blotting with the indicated
antibodies. C) The bands observed in theWestern blot shown in panel B were quantified using ImageJ. The graph represents the values obtained with this quantification,
normalized to the loading control (HSP70) and normalized to the values obtained at 0 h of cycloheximide treatment (CHX). D) Infected HeLa cells were treated with
5 mM phenanthroline for 30 min. The respective infected cell lysates were analyzed by Western blotting with the indicated antibodies.
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II and III remained constant. No decrease in the mRNA levels of
COX4 was observed (Supplementary Fig. 2B) indicating that the
drop in the protein level of COX4was due to a post-transcriptional
event, possibly proteolysis.
To test whether the absence of SLP-2 affects the turnover of
subunits of OXPHOS complexes as well as that of prohibitins,
HeLa cells were treatedwith cycloheximide (CHX, an inhibitor of
the synthesis of proteins encoded by nuclear genes) for 3, 6 and
9 h and the protein levels were monitored byWestern blotting. As
shown in Fig. 3B and C, the levels of ND6, COX4 and prohibitin-
1 were significantly decreased in SLP-2 depleted cells after 9 h of
CHX treatment (28±5.2%, 37±10.2% and 87±10.7%; n=4,
respectively) compared to control cells (6±2.3%, 14±6.7% and
18±6.2%; n=4, respectively). These results were confirmed using
SLP-2 depleted mouse embryonic fibroblasts (MEFs). In these
cells, both prohibitin-1 and 2 levels were found to be significantly
decreased 3 h after addition of cycloheximide (Supplementary
Fig. 2C; 67% and 30% respectively) compared to control cells
(90% and 97% respectively). These data suggest that cellular
depletion of SLP-2 enhances the degradation of specific subunits
of OXPHOS complexes as well as that of prohibitins.
In an effort to determine the proteolytic degradation process
responsible for the increased turnover of these proteins in SLP-2
depleted cells, we tested several protease inhibitors, including
caspase, proteasome and metalloprotease inhibitors. Only phe-
nanthroline, ametalloprotease inhibitor, was found to significantly
prevent the decrease in the level of these proteins (Fig. 3D and datanot shown). This suggests that metalloproteases, possibly AAA
proteases, are responsible for the degradation of ND6, COX4 and
prohibitin-1 in SLP-2 depleted cells.
3.4. Increased levels of SLP-2 in stressed mitochondria
Since it has been shown that under conditions of increased
mitochondrial protein turnover the levels of proteins involved in
the regulation of protein stability (e.g. prohibitin-1,Cpn60 [20,21])
increase, we examined the levels of SLP-2 under conditions of
mitochondrial stress such as those generated by cell exposure to
chloramphenicol (CAP), an inhibitor of the synthesis of proteins
encoded by the mitochondrial genome [22]. Here, we found that
the levels of SLP-2 were significantly increased in HeLa cells
(Fig. 4A; 192%±11.3%; n=5) and Cos-7 cells (Supplementary
Fig. 3; 156%±11.3%; n=3) treated with CAP. Furthermore, in
agreement with previous studies [20], prohibitin-1 was up-
regulated under the same conditions. Interestingly, levels of
HSP70, a known mitochondrial chaperone, remained constant
under these conditions, indicating that treating cells with CAP
leads to the up-regulation of specificmitochondrial stress response
proteins. Of note, levels of mitochondrial encoded proteins were
significantly decreased (33%±4.2%; n=4, data not shown), thus
validating CAP activity. In order to determine if the increase in the
levels of SLP-2 and prohibitin-1 was restricted to mitochondrial
specific stresses, HeLa cells were exposed to etoposide, a DNA
damaging agent, and the levels of SLP-2 and prohibitin-1 ex-
pression were determined. As shown in Fig. 4A, this treatment did
Fig. 4. SLP-2 and prohibitin-1 are both up-regulated during chloramphenicol
induced stress and the up-regulation of prohibitin-1 is SLP-2 dependent. A) HeLa
cells were treated with 100 μg/ml chloramphenicol (CAP) for 96 h and 100 µM
etoposide for 1 h. The levels of SLP-2 and prohibitin-1 were assessed by Western
blotting analysis of the cell lysates. GAPDH and HSP70 were used as a loading
control. B) Infected HeLa cells were described in Fig. 3A and were treated with
100 µg/ml chloramphenicol (CAP). 96 h after CAP treatment, the respective
infected cell lysateswere analyzed byWestern blottingwith the indicated antibodies.
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prohibitin-1, suggesting that SLP-2 and prohibitin-1 might be up-
regulated specifically in response to mitochondrial stress.
Sincewe have shown that SLP-2 is required tomaintain normal
prohibitin-1 levels and that prohibitin-1 increases in response to
mitochondrial stress,we testedwhether the increase in prohibitin-1
levels after CAP treatment was SLP-2 dependent. HeLa cells
depleted of SLP-2 were treated with CAP and the levels of
prohibitin-1 were assessed by Western blotting. As shown in
Fig. 4B, the increase in the protein levels of prohibitin-1 upon
CAP treatment was significantly reduced in SLP-2 depleted cells
(238%±16.2% in control cells compared to 147%±7.4% in SLP-s
depleted cells, n=3). This further indicates that SLP-2 is involved
in promoting the stability of prohibitin-1.
4. Discussion
Stomatins and stomatin like proteins such as SLP-2 are mem-
bers of a large family of proteins which also contains prohibitins,
HflK/C, flotillins, mechanoreceptors and plant defense proteins
[2,3]. Although it has been suggested that stomatins share a
common molecular function with other members of this super-
family, namely in the regulation of protein turnover, no ex-
perimental data has confirmed this hypothesis. Here, we show that
SLP-2 is a MIM protein that interacts with prohibitins and
depleting SLP-2 in HeLa cells and MEFs leads to an increased
proteolysis (possibly mediated by metalloproteases) of prohibi-
tins and of subunits of complexes I and IV. Further supporting the
role of SLP-2 in regulating the stability of specific mitochondrial
proteins, we found that SLP-2 is up-regulated under conditions of
mitochondrial stress leading to increased protein turnover.
It has previously been reported that SLP-2 is localized to the
plasma membrane of mature human erythrocytes [23]. How-ever, several proteomic studies of mitochondria obtained from
various cell types and different species have also identified
SLP-2 as a mitochondrial component [5–9]. In this study, we
further provide biochemical and immunocytochemical proofs
that SLP-2 is strongly associated with the MIM. Our finding is
in accordance with recent data published during the preparation
of this manuscript [24]. The localization of SLP-2 in the plasma
membrane of erythrocytes may be cell specific, and may result
from the absence of mitochondria in those cells. Another mito-
chondrial protein has been shown to have such a dual localization,
albeit in the same cell type: the mitochondrial β-chain ATP
synthase which is found both at the mitochondria and at the
plasma membrane [25].
Interestingly, unlike other members of the stomatin family,
SLP-2 does not contain any putative transmembrane domain.
Nevertheless, we found that SLP-2 is highly resistant to alkali and
PK treatments. We believe that these properties of the protein
could be due to SLP-2 being part of a high molecular weight
complex together with prohibitins (Supplementary Fig. 1A, C and
Fig. 2) in which the protein could be “buried”, thus making it less
accessible to PK. Since prohibitins are integral MIM proteins this
would also explain the resistance of SLP-2 to alkali treatment. An
additional, non-mutually exclusive explanation could be that
SLP-2 is associated with lipid microdomains that would resemble
raft structures. This hypothesis is based on the findings that
members of the stomatin family are associated to rafts and serve as
markers for the lipid microdomains [26].
Prohibitins are involved in diverse cellular processes such as
proliferation, aging and the assembly ofmitochondrial respiratory
complexes [27,28]. In yeast, they have been shown to interact
with two subunits of complex IV [16], and in mammals, with
components of complex I [9,29]. Consistently, prohibitins have
been shown to be required for stabilizing subunits of mitochon-
drial respiratory chain complexes and controlling their assembly
[16,18,19]. Here we show that protein levels of prohibitin-1
and prohibitin-2 are significantly decreased in SLP-2 depleted
cells, which suggests that SLP-2 may regulate the stability of
prohibitins through a direct or indirect interaction with this pro-
tein. It had been previously reported that following mitochondrial
stress induced by chloramphenicol (CAP), the levels of prohibitins
increase significantly [20]. Here we confirm this result and show
that SLP-2 is required for the increase in prohibitin-1 levels in cells
cultured with CAP. This result further supports the findings that
the stability of prohibitin-1 relies on SLP-2 directly or indirectly.
In addition to a drop in prohibitins levels, a decrease in the levels
of subunits of complexes I and IVof the respiratory chain was also
observed in SLP-2 depleted cells, thus suggesting that SLP-2 is
also required for the stability of other mitochondrial proteins such
as subunits of the OXPHOS complexes. Given the role of
prohibitins in the stability of various respiratory chain subunits in
yeast [16,18], it is possible that the decrease in the levels of these
proteins in SLP-2 depleted cells is the direct consequence of the
loss of prohibitins. Cellular depletion of SLP-2 causes an ac-
celerated degradation of prohibitins and subunits of complexes I
and IV that could be dependent onAAA proteases. These findings
suggest a regulatory function of the SLP-2/prohibitins complex
during membrane protein turnover by the AAA proteases. SLP-2/
911S. Da Cruz et al. / Biochimica et Biophysica Acta 1783 (2008) 904–911prohibitins could interfere with proteolysis by binding directly to
substrate proteins or by interacting directly with AAA proteases.
In support of the former hypothesis, it has been reported that the
bacterial proteases, HflK and HflC, two members of the SPFH
family, interact with the AAA protease FtsH in Escherichia coli
[19,30]. Moreover, in the hyperthermophilic archaebacterium
Pyrococcus horikoshii, a gene encoding a serine protease forms an
operon with a gene encoding a stomatin homolog and the two
proteins have been shown to work in the same pathway [31].
Altogether these data strongly suggest that SLP-2 could play a role
in the control of proteolysis in the mitochondria.
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